Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysis.

Wanner C, Feldt-Rasmussen U, Jovanovic A, Linhart A, Yang M, Ponce E, Brand E, Germain DP, Hughes DA, Jefferies JL, Martins AM, Nowak A, Vujkovac B, Weidemann F, West ML, Ortiz A

Open source

DOI: 10.1002/ehf2.12647
Published: 2020 Jun
Container: ESC heart failure
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ehf2.12647,
  title = {Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysis.},
  author = {Wanner C and Feldt-Rasmussen U and Jovanovic A and Linhart A and Yang M and Ponce E and Brand E and Germain DP and Hughes DA and Jefferies JL and Martins AM and Nowak A and Vujkovac B and Weidemann F and West ML and Ortiz A},
  year = {2020},
  journal = {ESC heart failure},
  doi = {10.1002/ehf2.12647},
  url = {https://doi.org/10.1002/ehf2.12647}
}

RIS

TY  - JOUR
TI  - Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysis.
AU  - Wanner C
AU  - Feldt-Rasmussen U
AU  - Jovanovic A
AU  - Linhart A
AU  - Yang M
AU  - Ponce E
AU  - Brand E
AU  - Germain DP
AU  - Hughes DA
AU  - Jefferies JL
AU  - Martins AM
AU  - Nowak A
AU  - Vujkovac B
AU  - Weidemann F
AU  - West ML
AU  - Ortiz A
PY  - 2020
JO  - ESC heart failure
DO  - 10.1002/ehf2.12647
UR  - https://doi.org/10.1002/ehf2.12647
ER  -

APA

C, W., U, F., A, J., A, L., M, Y., E, P., E, B., DP, G., DA, H., JL, J., AM, M., A, N., B, V., F, W., ML, W., & A, O. (2020). Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysis.. ESC heart failure. https://doi.org/10.1002/ehf2.12647

Source records

pubmed · retrieved 2026-09-27T10:23:15.134Z
europe-pmc · retrieved 2026-09-27T10:23:15.143Z
doaj · retrieved 2026-09-27T10:23:15.245Z
hal · retrieved 2026-09-27T10:23:15.165Z